Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (180) 180
humans (163) 163
respiratory system (94) 94
male (93) 93
female (90) 90
genetics & heredity (69) 69
middle aged (49) 49
mutation (46) 46
adult (44) 44
pulmonary fibrosis (36) 36
aged (35) 35
diagnosis (33) 33
idiopathic pulmonary fibrosis (28) 28
critical care medicine (26) 26
disease (24) 24
pedigree (23) 23
cardiac & cardiovascular systems (22) 22
interstitial lung disease (22) 22
lung diseases (22) 22
research (22) 22
exostoses, multiple hereditary - genetics (21) 21
child, preschool (19) 19
pirfenidone (19) 19
transplantation (19) 19
child (18) 18
care and treatment (17) 17
genetics (17) 17
abridged index medicus (16) 16
genetic aspects (16) 16
lung transplantation (16) 16
patients (16) 16
treatment outcome (16) 16
adolescent (15) 15
dna mutational analysis (15) 15
genes (15) 15
survival (15) 15
base sequence (14) 14
chromosome deletion (14) 14
family (14) 14
nintedanib (14) 14
phenotype (14) 14
animals (13) 13
fibrosis (13) 13
idiopathic pulmonary fibrosis - drug therapy (13) 13
idiopathic pulmonary-fibrosis (13) 13
management (13) 13
n-acetylglucosaminyltransferases - genetics (13) 13
respiratory tract diseases (13) 13
analysis (12) 12
biochemistry & molecular biology (12) 12
bronchoalveolar lavage (12) 12
health aspects (12) 12
hereditary multiple exostoses (12) 12
identification (12) 12
lung (12) 12
medical research (12) 12
pulmonary/respiratory (12) 12
safety (12) 12
aged, 80 and over (11) 11
chromosome mapping (11) 11
gene (11) 11
infant (11) 11
prognosis (11) 11
retrospective studies (11) 11
sarcoidosis (11) 11
studies (11) 11
syndrome (11) 11
clinical trials (10) 10
disease progression (10) 10
diseases of the respiratory system (10) 10
drug therapy (10) 10
expression (10) 10
ext1 (10) 10
mental-retardation (10) 10
molecular sequence data (10) 10
mutation, missense (10) 10
surgery (10) 10
usage (10) 10
young adult (10) 10
cloning (9) 9
efficacy (9) 9
exostoses (9) 9
gene mutations (9) 9
in situ hybridization, fluorescence (9) 9
medicine (9) 9
mice (9) 9
mutations (9) 9
pneumonia (9) 9
prevalence (9) 9
amino acid sequence (8) 8
capacity (8) 8
cells (8) 8
chromosome-11 (8) 8
chromosomes, human, pair 11 (8) 8
diagnosis, differential (8) 8
dna (8) 8
ectodermal dysplasia - genetics (8) 8
ext2 (8) 8
genetic testing (8) 8
guidelines (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Erratum to: “Differential diagnosis of usual interstitial pneumonia: when is it truly idiopathic?” Wim A. Wuyts, Alberto Cavazza, Giulio Rossi, Francesco Bonella, Nicola Sverzellati and Paolo Spagnolo. Eur Respir Rev 2014; 23: 308–319
European Respiratory Review, ISSN 0905-9180, 12/2014, Volume 23, Issue 134, p. 537
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Multiplex protein profiling of bronchoalveolar lavage in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis
by Stijn, Willems and Verleden Stijn, E and Vanaudenaerde Bart, M and Marijke, Wynants and Christophe, Dooms and Jonas, Yserbyt and Jana, Somers and Verbeken Eric, K and Verleden Geert, M and Wuyts Wim, A
Annals of Thoracic Medicine, ISSN 1817-1737, 01/2013, Volume 8, Issue 1, pp. 38 - 45
CONTEXT: Idiopathic pulmonary fibrosis (IPF) and chronic hypersensitivity pneumonitis (HP) are diffuse parenchymal lung diseases characterized by a mixture of... 
idiopathic pulmonary fibrosis | Bronchoalveolar lavage | hypersensitivity pneumonitis | interstitial lung disease | enzyme-linked immunosorbent assay | LUNG | ACTIVATION | STANDARDIZATION | CARDIAC & CARDIOVASCULAR SYSTEMS | ANGIOGENIC ACTIVITY | CHEMOKINES | BRONCHIOLITIS OBLITERANS SYNDROME | CLINICAL UTILITY | RESPIRATORY SYSTEM | AIRWAY COLONIZATION | GROWTH-FACTOR | SARCOIDOSIS | Bronchoscopy | Care and treatment | Usage | Pulmonary fibrosis | Hypersensitivity pneumonitis | Diagnosis | Research | Health aspects | Risk factors | Proteins | Angiogenesis | Lungs | Disease | Rodents | Family medical history | Patients | Alveoli | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Short and long-term effects of pulmonary rehabilitation in interstitial lung diseases: A randomised controlled trial
by Perez-Bogerd, Silvia and Wuyts, Wim and Barbier, Veronica and Demeyer, Heleen and Van Muylem, Alain and Janssens, Wim and Troosters, Thierry
Respiratory Research, ISSN 1465-9921, 09/2018, Volume 19, Issue 1, pp. 182 - 182
Background: Few data are available on the long-term effect of pulmonary rehabilitation (PR) and on long PR programs in interstitial lung diseases (ILD). We... 
FIBROSIS | CAPACITY | RESPIRATORY SYSTEM | EXERCISE TRAINING-PROGRAM | PIRFENIDONE | PREDICTORS | IMPROVEMENT | PHYSICAL-ACTIVITY | QUALITY-OF-LIFE | RESPIRATORY SOCIETY STATEMENT | HEALTH-STATUS | Humans | Middle Aged | Male | Treatment Outcome | Lung Diseases, Interstitial - diagnosis | Time Factors | Lung Diseases, Interstitial - rehabilitation | Outpatient Clinics, Hospital - trends | Exercise Tolerance - physiology | Female | Aged | Exercise - physiology | Lung Diseases, Interstitial - physiopathology | Usage | Lung diseases, Interstitial | Care and treatment | Exercise | Research | Health aspects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Response
by De Sadeleer, Laurens J and Wuyts, Wim A
Chest, ISSN 0012-3692, 09/2018, Volume 154, Issue 3, pp. 714 - 715
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Response
by De Sadeleer, Laurens J and Wuyts, Wim A
Chest, ISSN 0012-3692, 09/2018, Volume 154, Issue 3, pp. 714 - 715
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Response
by De Sadeleer, Laurens J and Wuyts, Wim A
Chest, ISSN 0012-3692, 09/2018, Volume 154, Issue 3, pp. 714 - 715
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease
by Hocking, LJ and Lucas, GJA and Daroszewska, A and Mangion, J and Olavesen, M and Cundy, T and Nicholson, GC and Ward, L and Bennett, ST and Wuyts, W and Van Hul, W and Ralston, SH
HUMAN MOLECULAR GENETICS, ISSN 0964-6906, 10/2002, Volume 11, Issue 22, pp. 2735 - 2739
Paget's disease of bone (PDB) is a common disorder characterized by focal abnormalities of increased and disorganized bone turnover. Genetic factors are... 
CHROMOSOME 18Q | KAPPA-B ACTIVATION | EXPANSILE OSTEOLYSIS | BIOCHEMISTRY & MOLECULAR BIOLOGY | GENETICS & HEREDITY | GENETIC-HETEROGENEITY | LOCI | RANK | BONE | TNFRSF11A | LINKAGE | P62 | Protein Structure, Tertiary | Sequestosome-1 Protein | Humans | Middle Aged | Ubiquitin - metabolism | Osteitis Deformans - metabolism | Male | Binding Sites - genetics | Case-Control Studies | Osteitis Deformans - genetics | DNA - genetics | Proteins | Carrier Proteins - genetics | Adaptor Proteins, Signal Transducing | Carrier Proteins - metabolism | DNA Mutational Analysis | Base Sequence | Carrier Proteins - chemistry | Female | Aged | Mutation | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text The aging lung: Tissue telomere shortening in health and disease
by Everaerts, Stephanie and Lammertyn, Elise J and Martens, Dries S and De Sadeleer, Laurens J and Maes, Karen and van Batenburg, Aernoud A and Goldschmeding, Roel and van Moorsel, Coline H.M and Dupont, Lieven J and Wuyts, Wim A and Vos, Robin and Gayan-Ramirez, Ghislaine and Kaminski, Naftali and Hogg, James C and Janssens, Wim and Verleden, Geert M and Nawrot, Tim S and Verleden, Stijn E and McDonough, John E and Vanaudenaerde, Bart M
Respiratory Research, ISSN 1465-9921, 05/2018, Volume 19, Issue 1, pp. 95 - 95
Background: Telomere shortening has been associated with several lung diseases. However, telomere length is generally measured in peripheral blood leucocytes... 
Chronic hypersensitivity pneumonitis | RAS | BOS | Cellular senescence | Chronic lung allograft dysfunction | Cystic fibrosis | Chronic obstructive pulmonary disease | Telomere length | SURVIVAL | LENGTH | AIRWAY-OBSTRUCTION | TRANSPLANTATION | OBSTRUCTIVE PULMONARY-DISEASE | AGE-RELATED DISEASE | RESPIRATORY SYSTEM | EMPHYSEMA | CYSTIC-FIBROSIS | ASSOCIATION | Aging | Telomeres | Research | Lungs | Health aspects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: A case series
by Delanote, Isabelle and Wuyts, Wim A and Yserbyt, Jonas and Verbeken, Eric K and Verleden, Geert M and Vos, Robin
BMC Pulmonary Medicine, ISSN 1471-2466, 11/2016, Volume 16, Issue 1, pp. 156 - 156
Background: Following recent approval of pirfenidone and nintedanib for idiopathic pulmonary fibrosis (IPF), questions arise about the use of these... 
Antifibrotics | Nintedanib | Safety | Pirfenidone | IPF | Lung transplantation | UNITED-STATES | CAPACITY | TRIALS | RESPIRATORY SYSTEM | Idiopathic Pulmonary Fibrosis - therapy | Tertiary Care Centers | Humans | Middle Aged | Graft Survival | Male | Lung - physiopathology | Postoperative Complications - epidemiology | Disease Progression | Vital Capacity | Lung Transplantation | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Indoles - adverse effects | Belgium | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Female | Indoles - therapeutic use | Aged | Pyridones - therapeutic use | Retrospective Studies | Pyridones - adverse effects | Care and treatment | Pulmonary fibrosis | Patient outcomes | Weight loss | Transplantation of organs, tissues, etc | Drug therapy | Health aspects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text First Data on Efficacy and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Forced Vital Capacity of ≤50 % of Predicted Value
by Wuyts, Wim A and Kolb, Martin and Stowasser, Susanne and Stansen, Wibke and Huggins, John T and Raghu, Ganesh
Lung, ISSN 0341-2040, 10/2016, Volume 194, Issue 5, pp. 739 - 743
In the Phase III INPULSIS® trials, 52 weeks’ treatment with nintedanib reduced decline in forced vital capacity (FVC) versus placebo in patients with... 
Tyrosine kinase | Clinical trial | Pneumology/Respiratory System | Medicine & Public Health | Interstitial lung diseases | Disease progression | Enzyme Inhibitors - adverse effects | Dyspnea - chemically induced | Humans | Middle Aged | Male | Diarrhea - chemically induced | Enzyme Inhibitors - therapeutic use | Disease Progression | Vital Capacity - drug effects | Indoles - adverse effects | Female | Indoles - therapeutic use | Aged | Idiopathic Pulmonary Fibrosis - physiopathology | Idiopathic Pulmonary Fibrosis - drug therapy | Pulmonary fibrosis | Research | Drug therapy | Patient outcomes | Vital signs | Product safety | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Nintedanib with add-on pirfenidone in idiopathic pulmonary fibrosis: Results of the INJOURNEY trial
by Vancheri, Carlo and Kreuter, Michael and Richeldi, Luca and Ryerson, Christopher J and Valeyre, Dominique and Grutters, Jan C and Wiebe, Sabrina and Stansen, Wibke and Quaresma, Manuel and Stowasser, Susanne and Wuyts, Wim A and INJOURNEY Trial Investigators
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 02/2018, Volume 197, Issue 3, pp. 356 - 363
Rationale: Nintedanib and pirfenidone slow the progression of idiopathic pulmonary fibrosis (IPF), but the disease continues to progress. More data are needed... 
Clinical trial | The destruction of the lung architecture | Myofibroblasts | Drug therapy | Interstitial lung diseases | Resulting in excessive deposition of extracellular matrix | clinical trial | drug therapy | MANAGEMENT | SAFETY | RESPIRATORY SYSTEM | adverse drug event | interstitial lung diseases | CRITICAL CARE MEDICINE | Severity of Illness Index | Drug Administration Schedule | Follow-Up Studies | Risk Assessment | Humans | Middle Aged | Male | Survival Rate | Treatment Outcome | Disease Progression | Dose-Response Relationship, Drug | Idiopathic Pulmonary Fibrosis - diagnosis | Idiopathic Pulmonary Fibrosis - mortality | Patient Safety | Female | Indoles - therapeutic use | Aged | Pyridones - therapeutic use | Drug Therapy, Combination | Idiopathic Pulmonary Fibrosis - drug therapy | Studies | Pulmonary fibrosis | Disease | Clinical trials | Fibroblasts | Clinical medicine | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: An international case-cohort study
by Walsh, Simon L.F and Maher, Toby M and Kolb, Martin and Poletti, Venerino and Nusser, Richard and Richeldi, Luca and Vancheri, Carlo and Wilsher, Margaret L and Antoniou, Katerina M and Behr, Jüergen and Bendstrup, Elisabeth and Brown, Kevin and Calandriello, Lucio and Corte, Tamera J and Cottin, Vincent and Crestani, Bruno and Flaherty, Kevin and Glaspole, Ian and Grutters, Jan and Inoue, Yoshikazu and Kokosi, Maria and Kondoh, Yasuhiro and Kouranos, Vasileios and Kreuter, Michael and Johannson, Kerri and Judge, Eoin and Ley, Brett and Margaritopoulos, George and Martinez, Fernando J and Molina-Molina, Maria and Morais, António and Nunes, Hilario and Raghu, Ganesh and Ryerson, Christopher J and Selman, Moises and Spagnolo, Paolo and Taniguchi, Hiroyuki and Tomassetti, Sara and Valeyre, Dominique and Wijsenbeek, Marlies and Wuyts, Wim and Hansell, David and Wells, Athol and IPF Project Consortium
European Respiratory Journal, ISSN 0903-1936, 08/2017, Volume 50, Issue 2, pp. 1700936 - 1700936
We conducted an international study of idiopathic pulmonary fibrosis (IPF) diagnosis among a large group of physicians and compared their diagnostic... 
MORTALITY | MANAGEMENT | PARENCHYMAL LUNG-DISEASE | RESPIRATORY SYSTEM | INTERSTITIAL PNEUMONIA | INTEROBSERVER AGREEMENT | UPDATE | Clinical Competence | Diagnosis, Differential | Reproducibility of Results | Prognosis | Humans | Middle Aged | Male | Dimensional Measurement Accuracy | International Cooperation | Diagnostic Techniques, Respiratory System - standards | Referral and Consultation - standards | Hospitals, University - standards | Idiopathic Pulmonary Fibrosis - diagnosis | Female | Pulmonologists - standards | Quality of Health Care - standards | Accuracy | Pulmonary fibrosis | Diagnosis | Experts | Lung diseases | Fibrosis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Effect of pirfenidone in patients with more advanced idiopathic pulmonary fibrosis
by Costabel, Ulrich and Albera, Carlo and Glassberg, Marilyn K and Lancaster, Lisa H and Wuyts, Wim A and Petzinger, Ute and Gilberg, Frank and Kirchgaessler, Klaus-Uwe and Noble, Paul W
Respiratory Research, ISSN 1465-9921, 03/2019, Volume 20, Issue 1, pp. 55 - 55
Data from controlled clinical studies in patients with more advanced idiopathic pulmonary fibrosis (IPF) could inform clinical practice, but they are limited,... 
Antifibrotic | Advanced disease | Lung function | Pirfenidone | Idiopathic pulmonary fibrosis | NINTEDANIB | CAPACITY | EFFICACY | SAFETY | RESPIRATORY SYSTEM | Medicine, Experimental | Complications and side effects | Medical research | Respiratory tract diseases | Care and treatment | Pulmonary fibrosis | Respiratory function | Lung | Medical treatment | Lung diseases | Medical services | Clinical trials | Patients | Subgroups | Quality of life | Medicine | Medical prognosis | Fibrosis | Clinical medicine | Safety | Index Medicus | Letter to the Editor
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Idiopathic pulmonary fibrosis: Time for greater expectations?
by Wuyts, Wim and Cottin, Vincent
European Respiratory Journal, ISSN 0903-1936, 08/2018, Volume 52, Issue 2, pp. 1801312 - 1801315
NINTEDANIB | TRIAL | EFFICACY | SAFETY | RESPIRATORY SYSTEM | COMBINATION THERAPY | PIRFENIDONE | ACETYLCYSTEINE | CLINICAL-COURSE | FORCED VITAL CAPACITY | Idiopathic Pulmonary Fibrosis | Vital Capacity | Indoles | Motivation | Humans | Life Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
by Balemans, W and Ebeling, M and Patel, N and Van Hul, E and Olson, P and Dioszegi, M and Lacza, C and Wuyts, W and Van den Ende, J and Willems, P and Paes-Alves, AF and Hill, S and Bueno, M and Ramos, FJ and Tacconi, P and Dikkers, FG and Stratakis, C and Lindpaintner, K and Vickery, B and Foernzler, D and Van Hul, W
Human Molecular Genetics, ISSN 0964-6906, 03/2001, Volume 10, Issue 5, pp. 537 - 543
Sclerosteosis is a progressive sclerosing bone dysplasia with an autosomal recessive mode of inheritance, Radiologically, it is characterized by a generalized... 
LOCALIZATION | TISSUE GROWTH-FACTOR | GENE | BIOCHEMISTRY & MOLECULAR BIOLOGY | CHROMOSOME 17Q12-Q21 | DISEASE | SEQUENCE | GENETICS & HEREDITY | BRCA1 | PHYSICAL MAP | REGION | FAMILY | Amino Acid Sequence | Bone Density | Humans | RNA, Messenger - genetics | Molecular Sequence Data | Chromosome Mapping | Genetic Markers | Proteins - genetics | Sequence Homology, Amino Acid | Osteochondrodysplasias - physiopathology | Osteochondrodysplasias - genetics | Chromosomes, Human, Pair 17 | DNA Mutational Analysis | Base Sequence | Protein Conformation | Bone Morphogenetic Proteins | DNA, Complementary | Genetic Linkage | SOST gene | van Buchem disease | sclerosteosis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text CNV-WebStore: Online CNV Analysis, Storage and Interpretation
by Vandeweyer, Geert and Reyniers, Edwin and Wuyts, Wim and Rooms, Liesbeth and Kooy, R Frank
BMC Bioinformatics, ISSN 1471-2105, 01/2011, Volume 12, Issue 1, pp. 4 - 4
Background: Microarray technology allows the analysis of genomic aberrations at an ever increasing resolution, making functional interpretation of these vast... 
VISUALIZATION | GENE PRIORITIZATION | ARRAY-CGH DATA | MENTAL-RETARDATION | HIDDEN-MARKOV MODEL | BIOCHEMICAL RESEARCH METHODS | COPY-NUMBER VARIATION | HUMAN GENOME | SNP GENOTYPING DATA | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | MATHEMATICAL & COMPUTATIONAL BIOLOGY | MICROARRAYS | INHERITANCE | Information Storage and Retrieval - methods | Internet | Oligonucleotide Array Sequence Analysis | Database Management Systems | Humans | Web applications | Usage | Information management | Genetic variation | Medical research | Cloud computing | Linux | Genomes | Perl | Clinical medicine | Arrays | Manuscripts | Programming languages | Methods | Validation studies | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Exercise training in patients with interstitial lung disease (ILD): Can reponders be distinguished from non-responders: Table 1
by Barbier, Veronica and Camillo, Carlos A and Demeyer, Heleen and Janssens, Wim and Wuyts, Wim and Troosters, Thierry
European Respiratory Journal, ISSN 0903-1936, 09/2015, Volume 46, Issue suppl 59, p. PA3530
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis
by Kreuter, Michael, Prof and Wuyts, Wim, MD and Renzoni, Elisabetta, MD and Koschel, Dirk, MD and Maher, Toby M, MD and Kolb, Martin, MD and Weycker, Derek, PhD and Spagnolo, Paolo, MD and Kirchgaessler, Klaus-Uwe, MD and Herth, Felix J F, MD and Costabel, Ulrich, MD
Lancet Respiratory Medicine, The, ISSN 2213-2600, 2016, Volume 4, Issue 5, pp. 381 - 389
Summary Background Gastro-oesophageal reflux disease is a potential risk factor for the development and progression of idiopathic pulmonary fibrosis (IPF). We... 
Pulmonary/Respiratory | Gastroesophageal Reflux - physiopathology | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Lung - physiopathology | Exercise Tolerance - drug effects | Disease Progression | Randomized Controlled Trials as Topic | Antacids - therapeutic use | Vital Capacity - drug effects | Clinical Trials, Phase III as Topic | Gastroesophageal Reflux - complications | Female | Aged | Idiopathic Pulmonary Fibrosis - complications | Idiopathic Pulmonary Fibrosis - physiopathology | Patient Admission - statistics & numerical data | Pyridones - therapeutic use | Gastroesophageal Reflux - drug therapy | Walk Test | Idiopathic Pulmonary Fibrosis - drug therapy | Care and treatment | Dosage and administration | Pulmonary fibrosis | Diagnosis | Antacids | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
19. Full Text Gastro-oesophageal reflux and idiopathic pulmonary fibrosis: In search of evidence
by Wuyts, Wim and Crestani, Bruno
European Respiratory Journal, ISSN 0903-1936, 09/2016, Volume 48, Issue 3, pp. 623 - 625
Gastro-oesophageal reflux (GOR) is a frequent comorbidity in many chronic respiratory conditions, particularly in idiopathic pulmonary fibrosis (IPF) [1].... 
SURGERY | HIATAL-HERNIA | THERAPY | ACID | RESPIRATORY SYSTEM | LAPAROSCOPIC FUNDOPLICATION | PREVALENCE | ASPIRATION | STAGE LUNG-DISEASE | PROGRESSION | TRANSPLANTATION | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights